CARCINOEMBRYONIC ANTIGEN - ANVISA Registration 80560310093

Access comprehensive regulatory information for CARCINOEMBRYONIC ANTIGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80560310093 and manufactured by manufacturer not specified. The registration is held by MEDLEVENSOHN COMÉRCIO E REPRESENTAÇÕES DE PRODUTOS HOSPITALARES LTDA with validity until Jul 03, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80560310093
2 Related Devices
Registration Details
ANVISA Registration Number: 80560310093
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

MedTeste CEA (Teste Rápido)
Risk Class III

Registration Details

80560310093

25351158760202351

05343029000190

Dates and Status

Jul 03, 2023

03/07/2033

09/18/2025 19:00:01

MedTeste CEA (Teste Rápido)
Risk Class III

Registration Details

80560310093

25351158760202351

05343029000190

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Jul 03, 2023

03/07/2033

09/18/2025 19:00:01